RCM
AGN

Reynolds Capital Management’s Allergan plc AGN Stock Holding History

Reynolds Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,100
Closed -$327K – 269
2015
Q1 		$327K Buy
+1,100
New +$314K 0.29% 134
2013
Q4 		– Sell
-1,400
Closed -$202K – 495
2013
Q3 		$202K Buy
+1,400
New +$186K 0.13% 350

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Reynolds Capital Management's AGN Position: Q2 2015 in Review

Reynolds Capital Management sold out of Allergan plc (AGN) in Q2 2015, closing a stake of 1,100 shares — an estimated $327K sold.

Reynolds Capital Management first reported a position in AGN in Q3 2013 and held it in 2 quarters. The position peaked at $327K in Q1 2015. 1,035 funds tracked by Wall St. Rank hold AGN as of Q2 2015.

  • Reynolds Capital Management reported no remaining Allergan plc position as of Q2 2015 after selling out during the quarter.
  • Reynolds Capital Management sold 1,100 Allergan plc shares in Q2 2015, an estimated $327K.
  • Reynolds Capital Management first reported a position in Allergan plc in Q3 2013 and held it in 2 quarters.
  • Reynolds Capital Management's Allergan plc position peaked at $327K in Q1 2015.
  • 1,035 funds tracked by Wall St. Rank held Allergan plc as of Q2 2015.

Based on Reynolds Capital Management's 13F filing for Q2 2015, filed 12 Aug 2015.